Leech extract: A candidate cardioprotective against hypertension-induced cardiac hypertrophy and fibrosis. (10th January 2021)

• Record Type: Journal Article
• Authors: Wang, Chien-Hao; Pandey, Sudhir; Sivalingam, Kalaiselvi; Shibu, Marthandam Asokan; Kuo, Wei-Wen; Yu-LanYeh, ; Viswanadha, Vijaya Padma; Lin, Yuan-Chuan; Liao, Shih-Chieh; Huang, Chih-Yang
• Is Part Of: Journal of ethnopharmacology. Volume 264(2020)
• Publication Date: 2021-01-10
• Subjects: Leech extract -- Cardiac -- Angiotensin II -- Hypertrophy -- Fibrosis; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2020.113346
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract : Ethnopharmacological relevance: The prevalence of cardiovascular diseases (CVDs) has been increasing worldwide. Despite significant improvements in therapeutics and on-going developments of novel targeted-treatment regimens, cardiac diseases lack effective preventive and curative therapies with minimal side effects. Therefore, there is an urgent need to identify and propagate alternative and complementary therapies against cardiovascular diseases. Some traditional Chinese medicines can contribute to the prevention and treatment of CVDs and other chronic diseases, with few side effects. Hirudo, a medicinal leech, has been acclaimed for improving blood circulation and overcoming blood stagnation; however, the precise molecular mechanisms of leech extract treatment against pathological cardiac remodeling remain elusive. In this study, we aimed to delineate the molecular mechanisms of medicinal leech extract in the treatment of cardiac hypertrophy and fibrosis, using both in vitro and in vivo assessments. Materials and methods: We conducted in vitro and in vivo animal experiments, including cell-viability assays, fluorescence microscopy, immunoblotting, immunohistochemistry, and Masson's trichrome staining. Results: Pre-treatment with leech extract conferred a survival benefit to spontaneously-hypertensive rats (SHRs) and significantly reduced angiotensin II (ANG II)-induced cardiac hypertrophy and fibrosis. ANG II-stimulated cardiac hypertrophy markers were attenuated by leech extract treatment, versus controls. Translational expression of stress-associated mitogen-activated protein kinases (MAPKs) was also repressed. In vivo, leech extract treatment significantly ameliorated the cardiac hypertrophy phenotype in SHRs and diminished interstitial fibrosis, accompanied with reduced fibrosis markers. Conclusion: Leech extract treatment under a hypertensive condition exerted significant cardio-protective benefits by reducing the expression of cardiac hypertrophy-related transcription factors, stress-associated MAPKs, and fibrosis mediators. Our findings imply that medicinal leach extract may be effective against hypertension-induced cardiac hypertrophy and fibrosis. Graphical abstract: Image 1 Highlights: Medicinal leech extract treatment has potential benefits against cardiac hypertrophy and fibrosis during stresses. Cardiac hypertrophy transcription factors, associated MAPKS, and fibrosis mediators were downregulated by leech extract treatment. This study provided evidence and incites for further evaluations of leechextract treatment to harness protective benefits against CVDs.